franckreporter
- Despite recent threats by President Trump to impose tariffs on pharmaceutical imports shortly, they are likely some weeks away.
- Sources in Europe and the U.S. told Reuters that the tariffs are not imminent.
- Earlier this month, Trump said tariffs on foreign-made pharmaceuticals could reach as high as 250%.
- Two sources told the news service that findings from a national security probe into semiconductors would come before a pharma tariffs announcement. Trump is also preoccupied with his meeting Friday with President Vladimir Putin regarding the war in Ukraine.
- Pharma companies are still awaiting the results of an investigation begun in April on the national security impacts of foreign drug production. Although Commerce Secretary Howard Lutnick has previously stated it would be completed by mid-June, it has yet to be released.
More on Bristol Myers Squibb, Pfizer
- Bristol Myers Squibb: Why I’m Pounding The Table On This Buying Opportunity
- Bristol-Myers Squibb: Buy The Weakness
- Bristol-Myers Squibb: Declines Have Gone Too Far
- Pfizer, Astellas post late-stage trial win for Padcev with Merck’s Keytruda in bladder cancer
- IO Biotech says cancer vaccine with Merck’s Keytruda outperformed in late-stage study